Intravenous diazepam application in a departmental convulsive status epilepticus protocol with CYP2C19 polymorphisms: a pediatric prospective cohort study
BMC Pharmacology and Toxicology · 05.06.2026 · 27 (1)
DOI: 10.1186/s40360-026-01159-3 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BMC Pharmacology and Toxicology, online erschienen am 05.06.2026. Verfasst von Muazzez Seker Gezici und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey. meceseker@gmail.com. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2C19, Diazepam, Anticonvulsants, Status Epilepticus. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Scientific Research Projects of Ege University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey. meceseker@gmail.com.
- Department of Pediatrics, Ege University, Izmir, Turkey. meceseker@gmail.com.
- Department of Pediatrics, Division of Pediatric Emergency, Ege University Faculty of Medicine, Izmir, Turkey.
- Department of Pediatrics, Division of Pediatric Genetics, Ege University Faculty of Medicine, Izmir, Turkey.
- Department of Pediatrics, Division of Pediatric Neurology, Ege University Faculty of Medicine, Izmir, Turkey.
Förderung
- Scientific Research Projects of Ege University
Zitieren
APA
Seker Gezici, M., Turan, C., Ayyildiz Emecen, D., Kanmaz, S., Isik, E., Yurtseven, A., Atik, T., Yilmaz, S. K., Tekgul, H., & Saz, E. U. (2026). Intravenous diazepam application in a departmental convulsive status epilepticus protocol with CYP2C19 polymorphisms: a pediatric prospective cohort study. BMC Pharmacology and Toxicology, 27(1). https://doi.org/10.1186/s40360-026-01159-3
Vancouver
Seker Gezici M, Turan C, Ayyildiz Emecen D, Kanmaz S, Isik E, Yurtseven A, et al. Intravenous diazepam application in a departmental convulsive status epilepticus protocol with CYP2C19 polymorphisms: a pediatric prospective cohort study. BMC Pharmacology and Toxicology. 2026;27(1). doi:10.1186/s40360-026-01159-3
BibTeX
@article{SekerGezici2026,
author = {Seker Gezici, Muazzez and Turan, Caner and Ayyildiz Emecen, Durdugul and Kanmaz, Seda and Isik, Esra and Yurtseven, Ali and Atik, Tahir and Yilmaz, Sanem Keskin and Tekgul, Hasan and Saz, Eylem Ulas},
title = {Intravenous diazepam application in a departmental convulsive status epilepticus protocol with CYP2C19 polymorphisms: a pediatric prospective cohort study},
journal = {BMC Pharmacology and Toxicology},
year = {2026},
volume = {27},
number = {1},
doi = {10.1186/s40360-026-01159-3}
}
EUVIMED